問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
China Medical University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2017-02-17 - 2020-12-17
Condition/Disease
Crohn’s Disease
Test Drug
Filgotinib
Participate Sites13Sites
Recruiting8Sites
Terminated3Sites
Division of General Internal Medicine
未分科
Active Crohn’s Disease
Filgotinib, 100 mg and 200 mg per tablet
Participate Sites14Sites
Recruiting9Sites
2015-09-01 - 2018-12-31
Active Systemic Lupus Erythematosus
Anifrolumab (MEDI-546) concentrate for solution for intravenous infusion
Participate Sites5Sites
Terminated4Sites
2018-01-01 - 2020-12-31
Chronic HBV Infection (Genotype A or B)
ARB-001467 Injection (2 mg/mL)
Participate Sites6Sites
Digestive System Department
2013-12-01 - 2022-12-31
Chronic Hepatitis B
1.Tenofovir Alafenamide (TAF, GS-7340)、 2.Tenofovir Disoproxil Fumarate (TDF, Viread®)
Participate Sites11Sites
Terminated11Sites
2018-05-25 - 2028-12-31
Rheumatoid Arthritis
Participate Sites10Sites
Recruiting1Sites
Terminated9Sites
2010-07-01 - 2011-09-30
Terminated10Sites
2007-09-01 - 2009-09-15
Participate Sites3Sites
2011-06-01 - 2014-12-31
Terminated14Sites
2012-06-01 - 2018-05-31
Terminated6Sites
全部
